-
1
Probing aspects of extracellular vesicle associated AAV allows increased vector yield and insight into its transduction and immune-evasive properties
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article -
2
A novel platform for engineered AAV-based vaccines
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article -
3
Development of cell lines with increased susceptibility to diverse adeno-associated viral vectors to enable in vitro potency assays
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article -
4
Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article -
5
Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington’s disease phenotypes
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article -
6
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article -
7
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution
Published 2025-03-01“…Molecular Therapy: Methods & Clinical Development…”
Get full text
Article